twenty-six essential hypertensive patients were entered into a protocol to assess the blood pressure and renal effects of the dihydropyridine calcium antagonist , nifedipine ( 30 to 120 mg/d given in divided dosage ) administered for twelve weeks .
C2945601
dihydropyridine calcium
C0028066
nifedipine